Netherlands Diabetes Market will reach US$ 3.36 Billion in 2028 according to the publisher. Diabetes is a chronic, life-threatening disease with no available cure. According to IDF Europe, there are more than 60 million diabetic people in the European Region; by 2045, this number will rise by 13%. In the Netherlands, the prevalence of diabetes mellitus (DM) is increasing rapidly. Netherlands' care for diabetes mainly concentrates on primary health care, with responsibility for most aspects of care in the hands of general practitioners.Netherlands Diabetes Industry was valued at US$ 2.62 Billion in 2022
Generally, primary health care in The Netherlands provides a good standard of care for subjects with diabetes mellitus. Another point of concern is the rise in the prevalence of obesity, leading to a vast increase in subjects with metabolic syndrome. Therefore, DM (diabetes mellitus) care and its provision will play an essential role in health care in The Netherlands.
Type 2 Diabetes will grow due to the rise in the Prevalence of Obesity
The Netherlands has observed a rise in the prevalence of type 2 diabetes during the last decade. This rise is due to the aging of Dutch population, and the incidence of obesity as a significant risk factor for diabetes is increasing; and multiple screening initiatives are being implemented. Netherlands Diabetes Industry was valued at US$ 2.62 Billion in 2022.According to the IDF, in 2019, 463 million people worldwide had diabetes, of whom approximately 1.1 million have type1. In the Netherlands, about 1.2 million people have diabetes, of which about 10% have type 1 diabetes. The factors that lead to type 1 diabetes can be both genetic and viral. In addition, the rise in the prevalence of weight gain also contributes to the increase in the disease.
Insulin Pen is predicted to grow at a significant rate during the Forecast Period
The Netherlands Market is segmented into Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring Devices, Insulin Pumps, and Insulin Pens. The prevalence of diabetes is increasing among all ages in the Netherlands, primarily due to increase in overweight and obesity, unhealthy diet, and physical inactivity. Therefore, the demand and market for insulin pens are increasing in the Netherlands. The rise is due to the availability of reimbursement of insulin pens and an increase in the diabetic population.Netherlands Diabetes Industry to expand at a CAGR of 4.23% from 2023 to 2028
The numbers of factors contributing to the high market share of insulin pumps in the Netherlands are as follows
- The growing aging population
- Increasing prevalence of diabetes
- Rising awareness regarding the benefits of the insulin pump
- High per capita disposable income
- Advanced diabetes infrastructure
Government Initiatives
The National Action program Diabetes (NAD) implementation in the Netherlands over the past decade has helped manage diabetes. It aims to inaugurate the Care Standard (CS) for diabetes using a particular implementation plan and to pilot it in several regions. For instance, Roche got CE Mark for its Accu-ChekSugarView app. Accu-ChekSugarView, the first app that examines blood glucose ranges by taking pictures with a Smartphone camera without requiring a blood glucose meter, in December 2019. Moreover, in 2018, The National Prevention Agreement was approved and set out ambitious goals to make the Netherlands healthier by 2040.Key Players:
The Netherlands Diabetes Market comprises major manufacturers, B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care.In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.
The report titled “Netherlands Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Insulin Pen (User, Types - Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Company (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of the Netherlands Diabetes Market.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
The Netherlands Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM) - Netherlands Diabetes Market breakup from four viewpoints1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG - Netherlands Diabetes Market breakup from five viewpoints
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market - Netherlands Diabetes Market breakup from six viewpoints
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market - Netherlands Diabetes Market breakup from four viewpoints
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. B. Braun Melsungen AG2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. Insulet Corporation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Table of Contents
1. Introduction2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Netherlands Diabetes Market
6. Netherlands Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Market Share - Netherlands Diabetes Market
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Netherlands Market & Users
8.1 Netherlands - CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Netherlands - CGM User
8.3 CGM Reimbursement in Netherlands
9. Blood Glucose Device (SMBG) - Netherlands Market & Users
9.1 Market
9.1.1 Type 1 Diabetes
9.1.2 Type 2 Diabetes
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement of Blood Glucose Devices inNetherlands
10. Insulin Pen - Netherlands Market & User
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen User
10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies
11. Insulin Pump - Netherlands Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Insulin Pump Market
11.1.2 Type 2 Insulin Pump Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in Netherlands
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 InsuletOmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue
14. SMBG - Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue
List of Figures:
Figure 01: Netherlands - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Netherlands - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Netherlands - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Netherlands - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Netherlands - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Netherlands - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Netherlands - Glucose Sensor Market Market (Million US$), 2017 - 2023
Figure 08: Netherlands - Forecast for Glucose Sensor Market Market (Million US$), 2023 - 2028
Figure 09: Netherlands - CGM Transmitter Market Market (Million US$), 2017 - 2023
Figure 10: Netherlands - Forecast for CGM Transmitter Market Market (Million US$), 2023 - 2028
Figure 11: Netherlands - CGM User (Thousand), 2017 - 2023
Figure 12: Netherlands - Forecast for CGM User (Thousand),2023 - 2028
Figure 13: Netherlands - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Netherlands - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Netherlands - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Netherlands - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Netherlands - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Netherlands - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Netherlands - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Netherlands - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Netherlands - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Netherlands - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Netherlands - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Netherlands - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Netherlands - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Netherlands - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Netherlands - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Netherlands - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Netherlands - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Netherlands - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Netherlands - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Netherlands - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Netherlands - Disposable Insulin Pen Market (Million US$), 2017 - 2023
Figure 34: Netherlands - Forecast for Disposable Insulin Pen Market (Million US$), 2023 - 2028
Figure 35: Netherlands - Reusable Insulin Pen Market (Million US$), 2017 - 2023
Figure 36: Netherlands - Forecast for Reusable Insulin Pen Market (Million US$), 2023 - 2028
Figure 37: Netherlands - Smart Insulin Pen Market (Million US$), 2017 - 2023
Figure 38: Netherlands - Forecast for Smart Insulin Pen Market (Million US$), 2023 - 2028
Figure 39: Netherlands - Disposable Insulin Pen User (Thousand), 2017 - 2022
Figure 40: Netherlands - Forecast for Disposable Insulin Pen User (Thousand), 2023 - 2028
Figure 41: Netherlands - Reusable Insulin Pen User (Thousand), 2017 - 2022
Figure 42: Netherlands - Forecast for Reusable Insulin Pen User (Thousand), 2023 - 2028
Figure 43: Netherlands - Smart Insulin Pen User (Thousand), 2017 - 2022
Figure 44: Netherlands - Forecast for Smart Insulin Pen User (Thousand), 2023 - 2028
Figure 45: Netherlands - Insulin Pen Needle Market Market (Million US$), 2017 - 2023
Figure 46: Netherlands - Forecast for Pen Needle Market Market (Million US$), 2023 - 2028
Figure 47: Netherlands - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 48: Netherlands - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 49: Netherlands - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 50: Netherlands - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 51: Netherlands - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 52: Netherlands - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 53: Netherlands - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 54: Netherlands - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 55: B. Braun Melsungen AG - Global Revenue (Billion US$), 2017 - 2022
Figure 56: B. Braun Melsungen AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 57: Eli Lilly - Global Revenue (Billion US$), 2017 - 2022
Figure 58: Eli Lilly - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 59: Terumo Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 60: Terumo Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 61: BD - Global Revenue (Billion US$), 2017 - 2022
Figure 62: BD - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 63: Novo Nordisk A/S - Global Revenue (Billion US$), 2017 - 2022
Figure 64: Novo Nordisk A/S - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 65: Ypsomed AG - Global Revenue (Billion US$), 2017 - 2022
Figure 66: Ypsomed AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 67: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 68: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 69: Insulet Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 70: Insulet Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 71: DarioHealth Corp - Global Revenue (Billion US$), 2017 - 2022
Figure 72: DarioHealth Corp - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 73: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 74: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 75: Dexcom Inc - Global Revenue (Billion US$), 2017 - 2022
Figure 76: Dexcom Inc - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 77: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 78: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 79: Tandem Diabetes Care - Global Revenue (Billion US$), 2017 - 2022
Figure 80: Tandem Diabetes Care - Forecast for Global Revenue (Billion US$), 2023 - 2028
List of Tables:
Table 01: Netherlands - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Netherlands - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
Companies Mentioned
- B. Braun Melsungen AG
- Eli Lilly and Company
- Terumo Corporation
- Becton, Dickinson (BD)
- Novo Nardisk
- Ypsomed AG
- Medtronic
- Insulet Corporation
- Abbott Laboratories
- DarioHealth Crop
- Dexcom, Inc
- Roche Diagnostic
- Tandem Diabetes Care
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2.62 Billion |
| Forecasted Market Value ( USD | $ 3.36 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Netherlands |
| No. of Companies Mentioned | 13 |
